Introduction to BCIs
Brain-computer interfaces (BCIs) are defined as systems that can determine functional intents, such as the desire to change or interact with something physical, directly from neural activity. They primarily consist of four parts: a device to measure brain activity, a computer to process these signals, an application to control the execution of the intended command, and a feedback system to ensure communication of the task’s completion.
BCIs are becoming increasingly popular in neurotech research for their implications in helping those with severe motor or physical disabilities interact with the physical world. However, as their capabilities are being further developed, privacy concerns are also beginning to emerge.
A Landmark Study
A recent study by Stanford’s Neural Prosthetics Translational Laboratory has demonstrated that brain-computer interfaces are able to accurately interpret the neural signals of imagined speech. In comparison, prior studies have largely focused on attempts to physically speak, which indicates this study has huge implications for patients suffering from more severe forms of paralysis.
Despite the benefits of this technology, one concern is immediately clear. The decoding of inner speech could enable unwanted speech to be translated aloud. Researchers have demonstrated the efficacy of a password-protected system that allows users to control when decoding begins, but is this a guarantee of privacy?
Physical Roadblocks in Developing BCIs
Another issue within the BCI field is the need for improvement in the hardware that these devices operate on. In an ideal world, BCIs would operate non-invasively, using dry electrodes that do not require skin abrasions or gel use. However, it is unclear if these EEG-based BCIs are able to remain easy-to-use, functional and reliable for long-term clinical issues. Since most of the current technology in the field has not reached the clinical stage and is still in the research stage, animal studies are the logical next step to demonstrate physical reliability.
Distributed control, the combination of neural signals from multiple brain areas between the cortex to the spinal cord, also has the potential to improve BCI performance. The natural muscle outputs within the CNS are based on contributions from many different regions of the brain, so mimicking this process could make BCIs more effective.
More specifically, BCIs could provide more autonomy to the user, producing outputs based on just the brain signals rather than the control of the BCI algorithm. An inclusive, user-centric design ensures that BCIs effectively cater to diverse communication styles and physical needs of users.
Data Privacy Concerns
Brain-computer interfaces, such as the one in the aforementioned Stanford study, use artificial intelligence to predict the intended actions. Specifically, they use a recurrent neural network (RNN) architecture to convert the brain activity of the imagined speech to a series of probabilities of the associated phonemes. The black-box nature of these neural networks pose another privacy concern. While RNNs have been proven effective in producing the correct outputs, the process behind their function remains a mystery, leading to a lack of trust.
Additionally, since the algorithm is making interpretations based on EEG or brain wave patterns, this technology could create unknown algorithmic biases or be misused by private entities because studies have demonstrated that personality traits are deducible from this data. This means that the brainwaves generated by users can potentially predict their mental intentions, beliefs, health information, race, gender, and personality traits in addition to their intended speech patterns.
Since many users of BCI have no transparency about what data is being used or shared, and no personal control over what is collected, obtaining informed consent for these types of technology can be difficult. This makes the users more vulnerable to predatory regulations and conditions of use.
History & Potential for Weaponization
The history of neurotechnology can be traced back to the late 19th century with the original discovery of the brain's electrical signals and the first electroencephalogram (EEG), which allows neural activity to be correlated with physical action.
The neurotechnology field first gained momentum in the late 20th century with early experiments using brain signals to control external devices, and it has since been propelled by advancements in computing and artificial intelligence. This rapid progress has attracted significant interest from military organizations like DARPA (the R&D arm of the U.S Department of Defense), which has invested millions of dollars in neurotechnology research.
While BCIs currently serve a dual purpose to treat injured soldiers and understand the human mind, this same technology holds the potential for weaponization. Even though BCIs are still in the early stages of their capabilities, the prospect of using such neurotechnology to enhance soldiers or create neuroweapons in the future is a serious concern given the levels of military investment.
It is important to look into whether this government involvement will be able to safeguard its citizens' cognitive freedom while promoting scientific advancement.
Stigma Around Neurotech Legislation
In order for neurotechnology to have a successful future, steps need to be taken to regulate it on a societal level. Although legislation is necessary to maintain the general safety of users, it is unclear to what extent the government has control over the subjective thoughts of their citizens.
This ambiguity surrounding the legality of neurological rights poses a significant barrier to adoption since current pieces of legislation like HIPAA or GDPR were not designed to cover the extent of neurotech. The increased stigma surrounding neurological rights is also reflected in existing court frameworks such as non-responsibility when dealing with cases of mental disability.
However, this is slowly changing as Chile became one of the first countries to pass neurorights legislation, focusing on safeguarding brain activity and legal restrictions on technology use. Three Democratic Senators also recently called for investigation into the development of BCIs because they could potentially “reveal mental health conditions, emotional states, and cognitive patterns, even when anonymized.” They cited a study reviewing the privacy policies of 30 neurotech companies, which stated the ability to share this personal data with third parties without consent.
Conclusion
Although there is much hope for brain-computer interfaces (BCIs), their widespread implementation faces significant hurdles. Balancing user autonomy with the potential for data misuse and lack of privacy makes it difficult to obtain true informed consent from users. Additionally, there are physical limitations that must be overcome such as the need for long term reliable and non-invasive hardware. The absence of specific legislation to protect user data collection will continue to impede further progress in large-scale distribution of neurotechnology. BCI technology in its current state is incredibly promising for a subset of patients, yet it is evident that more research and inter-agency collaboration is needed to ensure the responsible development for the larger population of individuals.